Target: â¹2,650
CMP: â¹2,551.15
Nestle India is among the prime beneficiaries of heightened consumer adoption of packaged foods. Current capex cycle of â¹6,400 crore for CY20-25 is likely to support the company in addressing segment demand more effectively.
Nestleâs thrust on penetration-led volume growth is helping it outperform sector volume growth. Strong pricing power is an added advantage and a likely factor of the faster margin recoup. Initiatives like âNestle Health Scienceâ and the pet foods foray are likely to keep the company at the forefront. FY26 P/E of 64x largely factors-in its strong business fundamentals and superior execution.
Nestle India has maintained its steady valuation march on the back of improved execution post the Maggi crisis. Strong positioning in niche foods & beverages has aided Nestle in logging better margins, healthy returns, and low working capital. Incremental thrust would be to expand the addressable market, where M&A can be tapped.
We initiate coverage on Nestle India with a REDUCE recommendation and Mar-25 TP of â¹2,650, based on 65x Mar-26 earnings. Any consumption slowdown in the formal sector would be a downside risk, while Nestle Indiaâs capability of utilising enhanced capacity ahead and driving innovation (aligning with Indian preferences) would be an upside risk.
Crime Today News | Markets | Commodities | Forex | Stocks
Source | Powered by Yes Mom Hosting
Crime Today News Agency